* Submits new drug applications in Japan and U.S. for Naldemedine for treatment of opioid-induced constipation Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
The post BRIEF-Shionogi & Co submits new drug applications in Japan and U.S. for naldemedine appeared first on NASDAQ.